Certified by Founder Lodge
Mozart Therapeutics, Inc
United States - Seattle, WA
START UP
1 Disclosed Funding Rounds $25,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Mozart is developing disease-modifying therapies for autoimmune and inflammatory diseases that work by targeting a novel regulatory immune pathway.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 08 ,2023 | Series A | $25,000,000 |
Eli Lilly and Company
ARCH Venture Partners
Pfizer
UPMC Enterprises
Sofinnova Partners
AbbVie
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
FOVC | $2,000,000 | (Jan 16, 2026)
CYB3R OPERATIONS | $5,400,000 | (Jan 16, 2026)
Project Eleven | $20,000,000 | (Jan 16, 2026)
depthfirst | $40,000,000 | (Jan 16, 2026)
Quadric | $30,000,000 | (Jan 16, 2026)
